BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, February 15, 2026
Home
»
Topics
»
Drugs
» Immuno-oncology
Immuno-oncology
RSS
ImmunoCellular Therapeutics completes enrollment in ICT-107 trial
Sep. 6, 2012
Phase I/II ublituximab trial begins in B-cell non-Hodgkin's lymphoma
Sep. 6, 2012
Innate Pharma cleared to begin phase II study of IPH-2102 in AML
Sep. 4, 2012
Lorus Therapeutics receives funding to support development of IL-17E
Sep. 4, 2012
VLST licenses CP-870893 from Pfizer
Sep. 3, 2012
Lead Nordic Nanovector product clear to enter clinic
Aug. 31, 2012
Genmab and Janssen Biotech form worldwide agreement
Aug. 31, 2012
Genmab designs novel CD74-directed immunotherapies
Aug. 29, 2012
TG Therapeutics highlights potential of ublituximab for new indication
Aug. 28, 2012
Updated results from EMILIA study of trastuzumab emtansine
Aug. 27, 2012
Previous
1
2
…
673
674
675
676
677
678
679
680
681
…
994
995
Next
RSS